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Abstract
Background: This systematic review aimed to evaluate the psychometric properties and clinical utility of all
condition specific outcome measures used to assess quality of life (QOL) in school aged children with cerebral
palsy (CP).
Methods: Relevant outcome measures were identified by searching 8 electronic databases, supplemented by
citation tracking. Two independent reviewers completed data extraction and analysis of the measures using a
modified version of the CanChild Outcome Measures Rating Form.
Results: From the 776 papers identified 5 outcome measures met the inclusion criteria: the Care and Comfort
Hypertonicity Questionnaire (C&CHQ), the Caregiver Priorities and Child Health Index of Life with Disabilities
(CPCHILD), CP QOL-Child, DISABKIDS and PedsQL 3.0 CP Module. There was evidence of construct validity for all
five measures. Content validity was reported for all measures except PedsQL 3.0. The CPCHILD and CP QOL-Child
were the only outcome measures to have reported data on concurrent validity. All measures, with the exception of
one (C&CHQ) provided evidence of internal reliability. The CPCHILD and the CP-QOL-Child had evidence of test-
retest reliability and DISABKIDS had evidence of inter-rater reliability. There were no published data on the
responsiveness of these outcome measures.
Conclusions: The CPCHILD and the CP QOL-Child demonstrated the strongest psychometric properties and clinical
utility. Further work is needed, for all measures, on data for sensitivity to change.
Background
Cerebral Palsy (CP) defines a group of conditions, arising
from an injury to the developing brain and occurs in 2.0
children per 1000 live births [1]. In addition to the distur-
bances of movement and posture including spasticity,
muscle weakness and reduced coordination, common
impairments of children with CP include disturbances of
sensation, perception, cognition, communication, beha-
viour, epilepsy, and secondary musculoskeletal problems
[2]. Reduced activity levels and participation restrictions
due to these impairments may lead to a reduced quality
of life (QOL), compared to their typically developing
peers [3-5]. The World Health Organization (WHO)
defines QOL as “an individual’s perception of their posi-
tion in life in the context of the culture and value systems
in which they live, and in relation to their goals, expecta-
tions, standards and concerns”[6]. Quality of life is also
defined as a person’s feelings of well-being across many
domains including physical, social, emotional and spiri-
tual aspects of life [7]. Outcome measures that purport to
evaluate QOL should take a broad approach to measur-
ing well-being, and not just measure on the functional
domain [8,9].
Quality of life measures can either be generic (that is,
measure well-being of any child, typically developing or
with a disability), for example the KIDSCREEN [10], or
be condition specific (that is, focuses specifically on a
defined population and tailors its questions to the issues
that might impact on the QOL of that population) [7].
Condition specific measures of QOL have a role to play
for children with cerebral palsy as they include all
domains unique to the population group, such as
physical functioning, adaptive equipment as well as
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specific measure is preferable to a generic measure in
that it is able to address the aspects of life which are
unique to a given population group. For example, a CP
specific outcome measure would be able to explore a
child’s feelings surrounding any adaptive equipment that
they require, or feelings surrounding medical, surgical or
therapeutic interventions, whereas these topics would be
beyond the scope of a generic outcome measure, thus
omitting potentially important aspects of daily life from
review. This review will focus on the role of condition
specific QOL measures as it is thought that such instru-
ments offer a greater depth of insight into the QOL of
children with CP [11]. As with all outcome measures,
measures of QOL should be valid, reliable, and respon-
sive to change for the population of interest while also
being easy to complete, analyse and access [12].
Increasingly, research and clinical practice is focusing
on interventions not only to improve biomechanical
alignment or functional outcomes for children with CP
but also to positively improve QOL. Clinicians need to
utilise outcome measures that accurately assess QOL in
these children to provide evidence that their manage-
ment strategies are influencing a child’sQ O L .T h ea i m
of this review therefore was to systematically identify all
available condition specific QOL outcome measures for
school aged children with CP, and to evaluate their psy-
chometric properties and clinical utility.
Methods
Search Strategy
Articles were identified from a systematic search of the
following computerized bibliographic databases:
CINAHL (1982-October 2009), Medline (1950-October
2009), EMBASE (1988-October 2009), AMED (1985-
October 2009), PsychINFO (1967-October 2009), PEDro
(1929-October 2009), the Cochrane Library and ERIC
(1966-October 2009). The keywords used were “quality
of life,”“ cerebral palsy,”“ children” and “outcome mea-
sure,” along with relevant MeSH terms and synonyms
and searches were combined to obtain the final yield.
Further articles were identified through citation tracking
using the Web of Science databases, manual checking of
the reference lists of included articles, and consultation
with experts in the field.
Inclusion/Exclusion Criteria
Outcome measures were included if they were designed
to measure quality of life, according to the WHO defini-
tion, in children with CP aged 4 to 18 years and were
written in English. This lower age limit was chosen so
as to make certain a correct diagnosis of CP.
O u t c o m em e a s u r e sw e r ee x c l u d e di ft h e yw e r eag e n -
eric QOL outcome measure or measured a construct
other than QOL such as functional or health status and
therefore did not meet the WHO definition. Functional
status was described as a child’s capacity to fulfill the
requirements of day-to-day living, including societal
contributions and personal up-keep [8], for example the
Pediatric Outcomes Data Collection Instrument. Health
status included a child’s level of health versus ill health,
incorporating symptoms and dysfunctions and disorder
management [8], for example the Child Health and Ill-
ness Profile. It is important to include only measures
based on a theoretical construct of QOL as measures of
function or health status; while related, do not specifi-
cally address the required definitional criteria of QOL.
Two independent reviewers (SC, KY) excluded papers
from the initial search yield on the basis of title and
abstract. Full text articles were sourced where the title
and abstract did not provide enough information about
whether the inclusion criteria were met. Any disagree-
ments over which papers to include or exclude were dis-
cussed with a third reviewer (RG) until a consensus was
reached.
Quality Assessment
Quality assessment was completed by the two indepen-
dent reviewers (SC, RG), using a modification of the
CanChild Outcome Measures Rating Form and Guide-
lines [13,14], an assessment scale that evaluates the psy-
chometric properties and clinical utility of outcome
measures (Appendix A). The modifications for the cur-
rent review, were (1) the sections of the rating form
focusing on the ICF domains of an individual’s ability to
perform activities and to participate in society were
omitted and (2) the remaining items were retabulated
for ease of use by reviewers. The performance of the
omitted items does not relate as directly to QOL as do
the feelings and perceptions regarding these life areas.
The modified form also considered the quality of the
publications from which information on each outcome
measure was sourced.
The modified rating form consisted of eleven items
which were applied to assess clinical utility (ease of
interpretation, feasibility, and how acceptable the mea-
sure was to assessors and respondents); and psycho-
metric properties; including scale construction,
standardization, reliability (internal consistency, retest,
and inter-rater), validity (content, concurrent and con-
struct) and responsiveness.
Evidence for each aspect of quality measurement was
scored as excellent (3 points), adequate (2 points), poor
(1 point), or a no evidence available option was given
(zero points). To be allocated 3 points there must have
been at least two high quality published papers report-
ing strong evidence for the outcome measure in ques-
tion. A score of 2 points required 1-2 well-designed
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studies were conducted; or poor levels of evidence
shown, a score of 1 was given. Such cut-offs were put
into place so that only outcome measures which had a
b o d yo fh i g h - q u a l i t ye v i d e n c e of psychometric proper-
ties, along with high levels of clinical utility would be
considered as excellent.
Data Extraction and Analysis
Data were extracted by two reviewers (SC, RG) using a
standardized form on the theoretic construct of the out-
come measure, the respondent(s), standardization mea-
sures available (for example a manual or administration
instructions), the target population, and the cost and
training involved. Information on validity, reliability and
responsiveness was also tabulated for each of the out-
come measures by the two reviewers (SC, RG), based on
the evidence sourced from publications. The quality of
psychometric properties and clinical utility were then
ranked by the two reviewers.
Results
The systematic search yielded 776 references of which
39 papers remained after review of the title and abstract.
The full text of these papers were retrieved and assessed
by two independent reviewers (SC, KY) and a further 31
papers were excluded (see Figure 1). Eight papers
reporting the five outcome measures met the full inclu-
sion criteria (Table 1). The condition specific QOL out-
come measures for school aged children with CP
identified were the Care and Comfort Hypertonicity
Questionnaire (C&CHQ) [15], the Caregiver Priorities
and Child Health Index of Life with Disabilities
(CPCHILD) [16,17], CP QOL-Child [18], DISABKIDS
[19-21], and the PedsQL 3.0 Cerebral Palsy Module [22]
(Table 1).
Three of the five measures used a grounded theory
and had their development based on the topics and
themes garnered from interviews with parents of chil-
dren with cerebral palsy, as well as health and care pro-
fessionals (CPCHILD, CP QOL-Child, DISABKIDS).
Importantly, the process for developing both the CP
QOL-Child and the DISABKIDS included discussion
and consultation with children who have CP. The basic
premise for the C&CHQ was sourced from an earlier
outcome measure, The Caregiver Questionnaire [23].
Information surrounding the development of the
PedsQL 3.0 states that research and clinical experience
were the primary basis of the questionnaire formulation.
Additional information was gathered through focus
groups and interviewing, though details of the group
participants were not provided.
All outcome measures were designed to be completed
by parents (parent report), and three of the five
measures also had a child report version, administered
to children eight years and older; CP QOL-Child [18],
DISABKIDS [19] and PedsQL 3.0 [22].
In the eight studies reporting the measures only four
papers reported on the GMFCS levels of participants
[16-18,22]. Of those reported, there was a greater repre-
sentation of children with skills classifications of
GMFCS level V (28%), and GMFCS level III (24%). Chil-
dren with a skills classification of GMFCS levels I and II
accounted for 34% of the reported population which is
lower than the 50% distribution reported in the CP Reg-
ister Australia’s 2009 inaugural report, detailing the
1993-2003 birth cohort [24].
Quality Assessment
Quality assessment found two outcome measures
(CPCHILD, CP QOL-Child) that were considered to be
of a high standard based on the aforementioned ratings.
Two measures (DISABKIDS and PedsQL 3.0) were con-
sidered to be moderately constructed, while the
C&CHQ was scored as a poor outcome measure on the
quality scale used (Table 2).
Theoretical constructs of outcome measures
The definition of QOL as described by Bjornson and
McLaughlin [7] compromised two components; QOL
should be assessed over broad domains, and also be a
measure of well-being. The CP QOL-Child was the only
measure to base its development on this theoretical con-
struct and measured well-being. Other identified out-
come measures phrased questions in the negative, thus,
not measuring well-being, but rather, ill-being. All five
identified measures fulfilled the requirement to measure
QOL over a number of areas of life (Table 2).
Evidence of Validity, Reliability and Responsiveness
The available data on the psychometric properties of the
five included measures are presented in Table 3. There
was evidence of construct validity for all five measures.
Three studies used the Gross Motor Function Classifica-
tion system (GMFCS) to assess construct validity
[16,17,22]. The PedsQL 3.0 reported discriminant valid-
ity on the basis that typically developing children scored
higher on average than children with CP. Four of the
five outcome measures reported content (face) validity
(C&CHQ, CPCHILD, CP QOL-Child and DISABKIDS).
Both the CPCHILD and CP QOL-Child reported data
on concurrent validity.
Four of the five outcome measures (CPCHILD, CP
QOL-Child, DISABKIDS, and PedsQL 3.0) reported
data on the internal reliability of the domains (Table 3).
There was evidence for retest reliability on two mea-
sures (CPCHILD, CP QOL-Child), and evidence of
inter-rater reliability for one measure (DISABKIDS).
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responsiveness of any of the included measures to change.
McCoy et al. [15] reported on the sensitivity of the
C&CHQ, noting an improvement of QOL score in chil-
dren when their dose of intrathecal baclofen was increased
to reduce spasticity. Varni et al. [22] reported on sensitivity
of the PedsQL 3.0 measure, finding that children with a
distribution of quadriplegia had a lower HRQOL than
children with hemiplegia and diplegia. It was also reported
that children with lower GMFCS scores representing a
higher functioning ability (GMFCS I and II) demonstrated
an increased HRQOL. Only one outcome measure (DIS-
ABKIDS) reported data on floor (0.3% in ‘overall’ domain)
and ceiling (2.3% in ‘overall’ domain and 1.7% in ‘physical’
domain) effects in the group sampled.
Clinical Utility
Analysis of clinical utility in the five included measures
found that four reported information on completion
time (CPCHILD, CP QOL-Chil d ,D I S A B K I D S ,P e d s Q L
3.0) (Table 4). The CPCHILD was expected to take 20-
30 minutes to complete, the CP QOL-Child 15-25 min-
utes, the DISABKIDS 20 minutes and the PedsQL 3.0
five minutes to complete. The cost of administering the
outcome measures was available for all of the five
instruments (Table 4). The C&CHQ, CPCHILD and the
CP QOL-Child were available free of charge for all
users.
Discussion
Ideally, therapists and researchers hoping to assess QOL
in children with CP should have a choice of valid, reli-
able, easy to administer, low cost instruments, suited to
the cultural and societal background of the children
involved. This review reported and evaluated the psy-
chometric properties and clinical utility of the condition
specific outcome measures currently used to measure
QOL in children with CP. Several areas were identified
Table 1 Data Extraction Summary Table
Study Outcome
Measure
Sample Size
Total(%
female)
Mean age Years,
months; SD (range)
Motor type and Distribution Functional Severity
GMFCS Levels (I-V)
McCoy,
et al. 2006
C&CHQ 47 (38) 10 ± 4 (3.1-21.1) Spasticity/dystonia -
Narayanan,
et al. 2006
CPCHILD 77 (42) 13.5 ± 3.4 (5-18) - I: 16% II: 4% III: 13%
IV: 14% V: 53%
Narayanan,
et al. 2007
CPCHILD 67 (37) Ambulatory CP: 8.3(5-18)
Non-Amb CP: 10.2 (5-18)
- I: 18% II:4% III: 21% IV:
16% V: 40%
Waters,
et al. 2007
CP QOL-Child 205 (45) 8.5 (4-12) - I: 18% II: 28% III: 14%
IV: 11% V: 27%
Baars, et al.
2005
DISABKIDS
(condition specific
module)
21 (overall pop.) 12.5 ± 2.5
(8-16)
--
Petersen,
et al. 2005
DISABKIDS (chronic
generic module)
21* (overall pop.) 12.5 ± 2.5
(8-16)
--
Schmidt,
et al. 2006
DISABKIDS (chronic
generic module)
91# 12.2 ± 2.8 (8-16) - Mild: 24.4%
Moderate: 48.8%
Severe: 26.8%
Varni, et al.
2006
PedsQL 3.0 241 (44) 8.1 ± 4.4 (2-18) Hemiplegia = 55 Diplegia = 84 Quadriplegia
= 85 Ataxia = 7 Diagnosis unavailable = 14
I: 11% II: 16% III: 35%
IV: 18% V: 15%
Note. Hyphens (-) indicate no published research, or information not available. *CP population as a part of a study with 360 children with chronic conditions
(asthma, arthritis, cerebral palsy, cystic fibrosis, dermatitis, diabetes, and epilepsy), 52% female. # CP population as a part of a study with 1153 children with
chronic conditions (asthma, arthritis, cerebral palsy, cystic fibrosis, dermatitis, diabetes, and epilepsy), 48% female.
Table 2 Quality Assessment Summary
Outcome Measure Clinical Utility (3) Scale Construction (3) Standardisation (3) Reliability (6) Validity (15) Overall Utility (3)
C&CHQ 11 1 0 4 1
CPCHILD 32 3 4 9 3
CP QOL-Child 33 3 4 9 3
DISABKIDS 32 3 4 7 2
PedsQL 3.0 31 2 3 6 2
Note. Total possible score for each domain in brackets.
Key: C&CHQ = Care and comfort hypertonicity questionnaire. CPCHILD = Caregiver priorities and child health index of life with disabilities. Clinical utility relates
to clarity of instructions. Scale construction includes assessment of relevant characteristics of construct and theoretical construct questionnaire developed under.
Reliability includes intra-rater, retest and internal consistency. Validity includes content, construct, criterion and responsiveness. Overall utility combines all
relevant information available for outcome measures.
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porting concurrent validity, retest reliability and the
responsiveness of the outcome measures. Based on the
collected psychometric and clinical utility data of the
included studies, the CPCHILD and the CP QOL-Child
were the strongest outcome measures for evaluating
Q O Li ns c h o o la g e dc h i l d r e nw i t hC P .T h eC PQ O L -
C h i l dw a st h eo n l yo u t c o m em e a s u r et oh a v eb e e n
developed with a firm theoretical underpinning of QOL.
In the process of identifying and evaluating available
outcome measures, the agreement of each to the
accepted definition of QOL was assessed. Only one out-
come measure fulfilled the two-part definitional criteria
of QOL being measured across broad domains and
being a measure of well-being (CP QOL-Child). It is
recommended that clinicians and researchers utilise out-
come measures that fulfil the requirements of the
accepted definition. Self-evaluation of well-being has
Table 3 Characteristics of selected quality of life measures
Outcome
Measure
Age Domains (no of
items)
Content Validity Concurrent
Validity
Construct
(convergent/
divergent)
Validity
Internal
Reliability
Retest (ICC)
Reliability
Care &
comfort
hypertonicity
questionnaire
(C&CHQ)
- 1) Personal care (8)
2) Positioning/Transfer
(7)
3) Comfort (5)
4)Interaction/
Communication (7)
Retrospective analysis
of patient notes and
interviews of experts.
- Higher scores were
referred to ITB
therapy, lower
scores to
Botulinum toxin.
--
Caregiver
priorities and
child health
index of life
with
disabilities
(CPCHILD)
5-12y 1) Personal care (8)
2) Positioning,
transferring & mobility
(8)
3) Comfort emotions
and behaviour (9)
4) Communication
and social interaction
(7)
5) Health (3)
6) Overall quality of
life (1)
Caregiver rated
importance of items
× = 3.95 on 6 point
ordinal scale (SD 0.63,
range 2.67-4.90)
Domains
moderately
correlated to
those of
CHQ and
PEDI
Higher GMFCS
scores correlated
with higher
CPCHILD scores
(worse outcome).
Convergent
(Spearman’s r): (w.
PEDI) Self Care
0.607 Mobility
0.619 Social
Function 0.518
a = 0.74-0.93
across all domains
0.97 total
questionnaire.
0.88-0.96
across the 6
domains. (95%
CI 0.88-0.99).
0.85 (95% CI:
0.68-0.93)
CP QOL-Child 4-12y 1) Social well-being
and acceptance
2)Participation and
physical health
3)Functioning
4)Emotional well-
being
5)Pain and impact of
disability
6)Access to services
7)Family
Self-report: 53 items.
Parent Proxy: 66 items
Domains determined
in consultation with
children with CP and
their parents (28
families)
Domains
moderately
correlated to
those of
KIDSCREEN
and CHQ
Global QOL r =
0.18-0.62
Global Health r =
0.21-0.56
a = 0.74-0.92
(caregivers)
(n = 205)
a = 0.80-0.90
(child-self report)
(n = 53)
0.76-0.89
DISABKIDS* 4-16y 1) Impact of disease
(10)
2) Communication (2)
Domains determined
in consultation with
children and their
parents (9 families).
- Discriminate: was
more able to
differentiate
between levels of
disability than CHQ
and KINDL
a = 0.71-0.91
Inter-rater
(concordance)
0.14-0.84 (across
scales)
-
PedsQL 3.0
CP Module
2-18y 1) Daily activities(9)
2) School activities (4)
3) Movement and
balance (5)
4) Pain and hurt (4)
5) Fatigue (4)
6) Eating activities (5)
7) Speech and
communication (4)
- - Discriminate: Able
to distinguish
between typically
developing
children and
children with CP.
Child Self-report:
0.77-0.93
-
Note. *DISABKIDS questionnaire for young people with cerebral palsy. Hyphens (-) indicate no published research, or information not obtained. PPC: Pearson’s
Correlation Coefficient. CHQ: Child health questionnaire. KIDSCREEN: a generic quality of life measure. KINDL: a generic health-related quality of life measure.
PEDI: Pediatric Evaluation of Disability Inventory.
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and feelings [25]; accordingly, outcome measures aiming
to assess QOL should be phrased to measure well-being
(for example CP QOL-Child), rather than shaping ques-
tions assuming ill-being (for example, DISABKIDS).
Furthermore, the assumption of difficulty, challenge and
ill-being in QOL outcome measures for children with
CP is not in keeping with the principles and the pur-
poses of these instruments. Quality of Life instruments
purpose to measure and explore feelings and daily life
experiences, and should not formulate questions which
assume to know a person’s state of being, simply due to
a condition they have.
All five outcome measures available to measure QOL
in school aged children with CP have limited evidence
of validity. In three studies [16,17,22] the GMFCS was
used to provide evidence for construct validity. Con-
struct validity refers to the degree to which an outcome
measure correlates to other measures, in a style uniform
with theoretically gained principles concerning the mea-
sured concept [26]. When a QOL measure has a large
focus on functionally based questions, it can be expected
that as GMFCS scores increase (representing a greater
gross motor impairment), the level of reported QOL is
reduced, as functional tasks become more difficult [27].
This correlation may not be seen between a generic
QOL measure and the GMFCS, as domains may not
cover relevant aspects of life for a child with cerebral
palsy. The GMFCS is a measure of motor function abil-
ity and not a QOL measure, thus correlations between
QOL outcome measures and the GMFCS do not neces-
sarily result in a valid QOL measure, but rather a mea-
sure that may differentiate across the spectrum of
functional severity. Similarly, discriminant validity for
the PedsQL 3.0 was reported on the basis that typically
developing children scored higher on average than chil-
dren with CP [22]. The PedsQL 3.0, as a QOL outcome
measure has an overemphasis on the functional
domains, for example, of the 35 items in the 13-18 year
old parent report, 23 items (66%) relate to functional
tasks. Participants are asked about the difficulty of com-
pleting tasks in their daily life, and considering that
poor physical function does not necessarily correlate
with an overall poor QOL [28,29] this method has
limitations.
With the exception of the CPCHILD and the CP QOL-
Child, outcome measures evaluated in this review did not
provide evidence to support their concurrent validity.
While there is no agreed ‘gold standard’ QOL measure to
compare these CP condition specific outcome measures
to, researchers could analyse the correlations between
their outcome measure and a combination of other
Table 4 Clinical utility of the selected QOL measures for children with CP
Outcome
Measure
Questionnaire
completed by
Completion Time
(minutes)
Cost Outcome Measure Description
C&CHQ Caregiver/Parent - No cost for use of questionnaire.
No manual available.
Designed to capture QOL
improvements as a result of reduced
tone post intrathecal baclofen (ITB)
treatment
CPCHILD Caregiver/Parent (5-12
yrs)
20-30 No cost for questionnaire or
manual.
Registration requested.
A measure of health status and well-
being for children with severe
cerebral
palsy, developed to measure
effectiveness of interventions
CP QOL-Child Caregiver/Parent (4-
12yrs)
Child (9-12 yrs)
15-25 No cost for questionnaire or
manual.
Registration requested.
A condition specific outcome
measure
intended to gauge and assess QOL
changes in children with cerebral
palsy
DISABKIDS Caregiver/Parent (4-16
yrs)
Child (4-16 yrs)
- Non-funded & Government funded
academic research*: free
Large non-commercial
organisation
research and evaluation*: free
Commercial studies*:
1000€ - 5000€
Intended to measure HRQOL and
assess burden of disease in children
and adolescents
PedsQL 3.0 Caregiver/Parent (2-18
yrs)
Child/Adolescent (5-
18 yrs)
5 Non-funded academic: free
Funded academic: $600US per
study
Large Non-Commercial: $1600US
Large commercial $5600-
$20,600US
Developed to assess HRQOL in a
population of children and
adolescents
with cerebral palsy
Note. Hyphens (-) indicate no published research, or information not available. *Purchase of 50€ manual and questionnaires required. #PedsQL standardised
guidelines for administration available at no cost.
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CP QOL-Child was validated against the KIDSCREEN, a
generic measure of QOL [18]. Such research needs to be
conducted to further strengthen the case for condition
specific QOL measures.
As QOL is a personal perspective of an individual’s
well-being, testing reliability may be seen by some as
problematic. In theory, it should be possible; with the
absence of any major life changes, the results of conse-
cutive applications of a QOL questionnaire should be
consistent. There was no evidence for re-test reliability
for three of the five QOL outcome measures; the
C&CHQ, DISABKIDS and PedsQL 3.0. An assessment
of re-test reliability for both the child and parent report
was conducted for the CP QOL-Child, with applications
of the questionnaire occurring at baseline and two
weeks. Additional questions were administered after the
two week period to gauge for any major life events dur-
ing that time. Given this limited evidence for re-test
reliability, it would be hard for clinicians and researchers
using these outcome measures to determine if changes
have really occurred following an intervention.
This review identified that there is a lack of data on
responsiveness, measurement error and minimally clini-
cally significant difference scores for all of the measures.
While the C&CHQ presented data on sensitivity to
change, there was a potential bias in that the parents
reporting the scores knew of the change in medical
management. As rehabilitation studies are rarely masked
to treatment allocation, it is problematic for parents to
report perceived QOL without knowledge of treatment
allocation, introducing bias. Information on sensitivity
and responsiveness is important as increasingly QOL
measures are being used in research studies. Until there
is empirical evidence on the sensitivity to change and
measurement error of these outcome measures, we can-
not properly interpret results obtained from these out-
come measures. The condition specific outcome
measures for measuring QOL have only recently been
developed, thus information regarding the appropriate
minimally clinically significant change for each of the
measures is now needed. It needs to be clear whether a
change in domain or total score correlates to a clinically
important change in QOL.
Ceiling and floor effect sizes were reported for only
one outcome measure (DISABKIDS chronic generic).
This scale was designed as a ‘chronic generic measure’,
including not only children with CP, but other paedia-
tric conditions, thus, some questions may not be as
appropriate as in other outcome measures. It is a posi-
tive indication of the validity of the given outcome mea-
sures if such effects did not generally occur. It would be
expected that ceiling and floor effects would only occur
if an outcome measure was inappropriately used on a
population, for example a commonly erroneously used
health status measure such as the PODCI, which is
often referred to as a measure of QOL [30].
During compilation of the studies in this review, the
lack of reported demographic details of the population
of interest in published works was evident. One short-
coming was the lack of information regarding the cogni-
tive abilities of children taking part in the self reporting
of QOL. Children with CP may have cognitive impair-
ments and such information is vital to researchers when
deciding on whether an outcome measure to assess
QOL is appropriate for a particular client or not. The
CPCHILD specifically focused on children with greater
physical impairment (children with GMFCS classifica-
tions III to V) and relied on parents’ report of their
child’s QOL [16].
Another point of interest was the wide age ranges that
were used in four of the studies [15-17,22]. When a small
population is dispersed over such a broad age range and
a spectrum of severity (GMFCS levels), questions of
validity of the child report of results may arise. Consid-
eration of the appropriateness and relevance of questions
across the spectrum of age and severity is needed as
there may be incredible variation in life experiences pre-
sent between children of different ages and GMFCS
levels. It is questionable whether items relevant to a
group of primary school aged children would be equally
relevant and have the same priority as QOL questions for
adolescent aged children. It is recommended that condi-
tion specific tools of QOL are developed and validated
for specific age bands (child, teenager and adult), to cap-
ture the most meaningful and important data.
A limitation of this review was that potentially rele-
vant articles were excluded if they were not written in
the English language. Other limitations were the rela-
tively recent development of the QOL outcome mea-
sures, resulting in a paucity of data on the ability of the
measures to detect clinically important changes in QOL
due to interventions.
Conclusions
Taking into account the evidence for reliability and
validity, the ease of access, the relatively quick comple-
tion time, and the free availability, the CP QOL-Child
and the CPCHILD were found to be the strongest mea-
sures of QOL in children with CP. The CP QOL-Child
was the only measure which wholly fulfilled the defini-
tional criteria of QOL. As yet however, there is no data
published on sensitivity and limited data on the child
report questionnaire for the CP QOL-Child. More
broadly, the term “Quality of Life” is used with much
inconsistency. Both research and clinical practice would
benefit from the uniform understanding and use of an
agreed, consensus driven definition.
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Quality Analysis (Adapted) Outcome Measures Rating Form CanChild Centre for Disability Research, Institute of
Applied Health Sciences, McMaster University
CLINICAL UTILITY Clarity of Instructions □ Excellent (clear, comprehensive, concise, and available)
□ Adequate (clear, concise, but lacks some information)
□ Poor (not clear and concise or not available)
SCALE
CONSTRUCTION
Item Selection □ Excellent (included all relevant characteristics of attribute based on comprehensive review
and survey of experts)
□ Adequate (included most relevant characteristics of attribute)
□ Poor (convenient sample of characteristics of attribute, or questionnaire not available)
STANDARDIZATION Manual □ Excellent: published manual which outlines specific procedures for administration; scoring
and interpretation; evidence of reliability and validity
□ Adequate: manual available and generally complete but some information is lacking or
unclear regarding administration; scoring and interpretation; evidence of reliability and validity
□ Poor: no manual available or manual with unclear administration; scoring and interpretation;
no evidence of reliability and validity
RELIABILITY Rigor of standardization
studies for reliability
□ Excellent: > 2 well-designed reliability studies completed with adequate to excellent reliability
□ Adequate: 1 to 2 well-designed reliability studies completed with adequate to excellent
reliability
□ Poor: reliability studies poorly completed, or reliability studies showing poor levels of
reliability
□ No evidence available
Reliability Information Type of Reliability
Statistic Used
Value
Rating (excellent, adequate or poor)
NB Excellent: > .80 Adequate:.60 -.79, Poor: < .60
VALIDITY Rigor of standardization
studies for validity
□ Excellent: more than 2 well-designed validity studies supporting the measure’s validity
□ Adequate: 1 to 2 well-designed validity studies supporting the measure’s validity
□ Poor: validity studies poorly completed or did not support the measure’s validity
□ No evidence available
Content Validity □ Excellent: judgmental or statistical method (e.g. factor analysis) was used the measure is
comprehensive and includes items suited to the measurement purpose
Method: □ judgmental □ statistical
□ Adequate: has content validity but no specific method was used
□ Poor: instrument is not comprehensive
□ No evidence available
Construct Validity □ Excellent: more than 2 well designed studies have shown that the instrument conforms to
prior theoretical relationships among characteristics or individuals
□ Adequate: 1 to 2 studies demonstrate confirmation of theoretical formulations
□ Poor: construct validation poorly completed, or did not support measure’s construct validity
□ No evidence available
Criterion Validity □ Concurrent □ Predictive Criterion Measure used:
□ Excellent: > 2 well-designed studies showing adequate agreement with a criterion or gold
standard
□ Adequate: 1-2 studies demonstrate adequate agreement with a criterion or gold standard
measure
□ Poor: criterion validation poorly completed or did not support measure’s criterion validity
□ No evidence available
RESPONSIVENESS □ Excellent: more than 2 well-designed studies showing strong hypothesized relationships
between changes on the measure and other measures of change on the same attribute.
□ Adequate: 1-2 studies of responsiveness
□ Poor: studies of responsiveness poorly completed or did not support the measure’s
responsiveness
□ No evidence available
OVERALL UTILITY □ Excellent: adequate to excellent clinical utility, easily available, excellent reliability and validity
□ Adequate: adequate to excellent clinical utility, easily available, adequate to excellent
reliability and adequate to excellent validity
□ Poor: poor clinical utility, not easily available, poor reliability and validity
Carlon et al. BMC Pediatrics 2010, 10:81
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